These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma. Millanta F; Caneschi V; Ressel L; Citi S; Poli A J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688 [TBL] [Abstract][Full Text] [Related]
3. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer. Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848 [TBL] [Abstract][Full Text] [Related]
5. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer. de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639 [TBL] [Abstract][Full Text] [Related]
6. Profile of Steroid Receptors and Increased Aromatase Immunoexpression in Canine Inflammatory Mammary Cancer as a Potential Therapeutic Target. De Andrés PJ; Cáceres S; Clemente M; Pérez-Alenza MD; Illera JC; Peña L Reprod Domest Anim; 2016 Apr; 51(2):269-75. PubMed ID: 26899138 [TBL] [Abstract][Full Text] [Related]
7. Metastasis of canine inflammatory versus non-inflammatory mammary tumours. Clemente M; Pérez-Alenza MD; Peña L J Comp Pathol; 2010; 143(2-3):157-63. PubMed ID: 20427049 [TBL] [Abstract][Full Text] [Related]
8. Expression and the molecular forms of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase 9 in canine mammary tumours. Chen YC; Chang SC; Huang YH; Lee YJ; Chang CC; Liao JW; Hsu WL Vet Comp Oncol; 2019 Sep; 17(3):427-438. PubMed ID: 31050171 [TBL] [Abstract][Full Text] [Related]
9. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer. Clemente M; Pérez-Alenza MD; Illera JC; Peña L Vet Pathol; 2010 Mar; 47(2):265-74. PubMed ID: 20106772 [TBL] [Abstract][Full Text] [Related]
11. P-Glycoprotein and Breast Cancer Resistance Protein in Canine Inflammatory and Noninflammatory Grade III Mammary Carcinomas. Levi M; Peña L; Alonso-Díez A; Brunetti B; Muscatello LV; Benazzi C; Pérez-Alenza MD; Sarli G Vet Pathol; 2019 Nov; 56(6):840-847. PubMed ID: 31526115 [TBL] [Abstract][Full Text] [Related]
12. Establishment of a new cell line of canine inflammatory mammary cancer: IMC-118. Gao H; Zhou H; Gao Y; He L; Li W; Xu M; Feng H; Feng X; Qiu C Vet Comp Oncol; 2022 Sep; 20(3):679-687. PubMed ID: 35429113 [TBL] [Abstract][Full Text] [Related]
13. First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases. Pérez-Alenza MD; Jiménez A; Nieto AI; Peña L Breast Cancer Res; 2004; 6(4):R300-7. PubMed ID: 15217496 [TBL] [Abstract][Full Text] [Related]
14. Activation of Mammalian target of rapamycin in canine mammary carcinomas: an immunohistochemical study. Delgado L; Gärtner F; Dias Pereira P J Comp Pathol; 2015; 152(2-3):138-44. PubMed ID: 25670666 [TBL] [Abstract][Full Text] [Related]
15. Cell adhesion molecules E-cadherin and CADM1 are differently expressed in canine inflammatory mammary cancer. Alonso-Diez A; Affolter VK; Sevane N; Dunner S; Valdivia G; Clemente M; De Andrés PJ; Illera JC; Pérez-Alenza MD; Peña L Res Vet Sci; 2022 Dec; 152():307-313. PubMed ID: 36084372 [TBL] [Abstract][Full Text] [Related]
16. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours. Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues. Gama A; Gärtner F; Alves A; Schmitt F Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036 [TBL] [Abstract][Full Text] [Related]
18. Exploring new biomarkers in the tumour microenvironment of canine inflammatory mammary tumours. Raposo TP; Pires I; Prada J; Queiroga FL; Argyle DJ Vet Comp Oncol; 2017 Jun; 15(2):655-666. PubMed ID: 26778136 [TBL] [Abstract][Full Text] [Related]
19. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53. Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357 [TBL] [Abstract][Full Text] [Related]
20. The role of CD44 adhesion factor in canine mammary carcinomas. Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]